CHILDREN'S DIMETAPP COLD & COUGH OTC
Generic Name and Formulations:
Brompheniramine maleate 1mg, dextromethorphan HBr 5mg, phenylephrine HCl 2.5mg; per 5mL; syrup; grape-flavor; alcohol-free; contains sodium 3mg/5mL.
Pfizer Consumer Healthcare
Indications for CHILDREN'S DIMETAPP COLD & COUGH:
Cough, nasal congestion, rhinorrhea, allergy symptoms.
20mL every 4 hours; max 6 doses/24 hours.
<6yrs: do not use. 6–11yrs: 10mL every 4 hours; max 6 doses/24 hours.
Children <6yrs old. During or within 14 days of MAOIs. For use as a sedative hypnotic.
Cardiovascular disease. Hypertension. Thyroid disease. Diabetes. GI or GU obstruction. Glaucoma. Asthma. Lower respiratory disorders. Pregnancy. Nursing mothers.
Antihistamine + antitussive + sympathomimetic.
See Contraindications. Hypertensive crisis with MAOIs. β-blockers may increase pressor effects of sympathomimetics. Antihypertensives antagonized. Avoid alcohol. Increased CNS effects with other CNS depressants.
Drowsiness, anticholinergic effects, nervousness, dizziness, insomnia, excitability in children.
Syrup—4oz, 8oz (w. dosing cup)
Neurology Advisor Articles
- High-Dose Biotin May Be an Effective Treatment for Progressive MS
- Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
- Patients With Multiple Sclerosis Face Greater Infection Risk
- Fingolimod Compared With Glatiramer Acetate in Head-to-Head MS Study
- Lower Relapse Risk and Disability Progression With Oral DMT in Treatment-Naive RRMS
- Anodal tDCS Offers Possible Benefit for Improving Item Recall in Post-Stroke Aphasia
- Hospitalization Tied to Brain Abnormalities in Older Adults
- Spending Often Persists in High-Cost Medicare-Medicaid Eligible
- Skills-Based Intervention Did Not Cut Systolic BP After Stroke, TIA
- High Frequency of Headaches Following Dialysis Associated With BUN and Blood Pressure